Trials / Conditions / Hypertension and Dyslipidemia

Hypertension and Dyslipidemia

15 registered clinical trials studyying Hypertension and Dyslipidemia.

Status	Trial	Sponsor	Phase
Completed	A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg NCT05698043	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5) NCT05749861	Chong Kun Dang Pharmaceutical	Phase 1
Completed	Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 NCT05549401	Chong Kun Dang Pharmaceutical	Phase 1
Completed	Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fast NCT05552495	Chong Kun Dang Pharmaceutical	Phase 1
Completed	Study to Evaluate the Safety and Pharmacokinetics of CKD-331 NCT05335044	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg NCT05245084	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) NCT05192356	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg NCT04987970	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) NCT04883658	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) NCT04694989	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 NCT04673864	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 NCT04660370	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 NCT04587206	Chong Kun Dang Pharmaceutical	Phase 1
Completed	A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia NCT04554953	Boryung Pharmaceutical Co., Ltd	—
Completed	Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisar NCT02933658	Daewon Pharmaceutical Co., Ltd.	Phase 1